Laquinimod 0.3 ( DrugBank: Laquinimod )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
13	多発性硬化症／視神経脊髄炎	1

13. 多発性硬化症／視神経脊髄炎

---

臨床試験数 : 3,342 /  薬物数 : 2,355 - (DrugBank : 406) / 標的遺伝子数 : 269 - 標的パスウェイ数 : 241

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00349193 (ClinicalTrials.gov)	March 2005	26/6/2006	A Study to Evaluate the Effectiveness, Tolerability and Safety of Laquinimod	A Multinational, Multicenter Randomized Double-Blind, Parallel-Group, Placebo-Controlled Study, to Evaluate the Efficacy, Tolerability and Safety of Two Doses of, Oral Laquinimod in Relapsing Remitting (R-R) Multiple Sclerosis (MS) Subjects	Relapsing Remitting Multiple Sclerosis	Drug: laquinimod 0.3;Drug: laquinimod 0.6;Other: Placebo	Teva Pharmaceutical Industries	NULL	Completed	18 Years	50 Years	Both	306	Phase 2	Italy